{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:31:07Z","timestamp":1789086667160,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.humpath.2022.06.009","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T11:33:59Z","timestamp":1655206439000},"page":"176-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-4908","authenticated-orcid":false,"given":"Claudio","family":"Luchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2022.06.009_bib1","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2022.06.009_bib2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.humpath.2022.06.009_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10689-007-9145-9","article-title":"The biochemical basis of microsatellite instability and abnormal immunohistochemistry and\u00a0clinical behavior in Lynch syndrome: from bench to bedside","volume":"7","author":"Boland","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib5","first-page":"675","article-title":"Cancer of the microsatellite mutator phenotype","volume":"377","author":"Perucho","year":"1996","journal-title":"Biol Chem"},{"key":"10.1016\/j.humpath.2022.06.009_bib6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.21037\/atm-20-2920","article-title":"Alterations of DNA damage repair in cancer: from mechanisms to applications","volume":"8","author":"Jiang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.humpath.2022.06.009_bib7","first-page":"145","article-title":"Molecular analysis of an intestinal neuroendocrine\/non-neuroendocrine neoplasm (MiNEN) reveals MLH1 methylation-driven microsatellite instability and a monoclonal origin: diagnostic and clinical implications","volume":"30","author":"Sciammarella","year":"2022","journal-title":"Appl Immunohistochem Mol Morphol AIMM"},{"key":"10.1016\/j.humpath.2022.06.009_bib8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1097-0142(19850815)56:4<939::AID-CNCR2820560440>3.0.CO;2-T","article-title":"Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies","volume":"56","author":"Lynch","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib9","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#","article-title":"Extracolonic cancer in hereditary nonpolyposis colorectal cancer","volume":"71","author":"Watson","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib10","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/bjc.1998.124","article-title":"Molecular pathogenesis of sporadic duodenal cancer","volume":"77","author":"Achille","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2022.06.009_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gcc.23015","article-title":"Mismatch repair deficiency: the what, how and why it is important","volume":"61","author":"Olave","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.gastro.2014.09.038","article-title":"Association between molecular subtypes of colorectal cancer and patient survival","volume":"148","author":"Phipps","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2022.06.009_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/curroncol29020063","article-title":"Endometrial cancer: transitioning from histology to genomics","volume":"29","author":"Mitric","year":"2022","journal-title":"Curr Oncol Tor Ont"},{"key":"10.1016\/j.humpath.2022.06.009_bib16","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.humpath.2022.06.009_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13402-012-0072-x","article-title":"Multivariate analysis of immunohistochemical evaluation of protein expression in pancreatic ductal adenocarcinoma reveals prognostic significance for persistent Smad4 expression only","volume":"35","author":"Ottenhof","year":"2012","journal-title":"Cell Oncol Dordr"},{"key":"10.1016\/j.humpath.2022.06.009_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cancergencyto.2008.09.008","article-title":"Simulation-based analyses reveal stable microsatellite sequences in human pancreatic cancer","volume":"189","author":"Fujii","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.humpath.2022.06.009_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046002","article-title":"Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma","volume":"7","author":"Laghi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2022.06.009_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/modpathol.2015.89","article-title":"Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma","volume":"28","author":"Riazy","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib21","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-17-3099","article-title":"Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: challenges and recommendations","volume":"24","author":"Hu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.06.009_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-320726","article-title":"Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications","volume":"70","author":"Luchini","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.06.009_bib23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1136\/gutjnl-2020-320730","article-title":"Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma","volume":"70","author":"Grant","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.06.009_bib24","first-page":"1501","article-title":"Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+","volume":"152","author":"Goggins","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65035-3","article-title":"Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity","volume":"156","author":"Wilentz","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.path.2016.05.003","article-title":"Pancreatic ductal adenocarcinoma and its variants","volume":"9","author":"Luchini","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2022.06.009_bib27","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2017.11.009","article-title":"Prevalence of microsatellite instability in intraductal papillary mucinous neoplasms of the pancreas","volume":"154","author":"Lupinacci","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humpath.2022.06.009_bib28","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gutjnl-2018-316151","article-title":"Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management","volume":"67","author":"Scarpa","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.06.009_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00428-011-1080-3","article-title":"Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status","volume":"459","author":"Bae","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.06.009_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/00000478-200311000-00002","article-title":"Value of histopathology in predicting microsatellite instability in hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer","volume":"27","author":"Shia","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153519","article-title":"Colorectal cancer with microsatellite instability: right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival","volume":"224","author":"Piredda","year":"2021","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2022.06.009_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-323805","article-title":"Microsatellite instability\/mismatch repair deficiency in pancreatic cancers: the same or different?","author":"Luchini","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.06.009_bib33","first-page":"JCO2001364","article-title":"Metastatic pancreatic cancer: ASCO guideline update","author":"Sohal","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.19.02105","article-title":"Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study","volume":"38","author":"Marabelle","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib35","article-title":"Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites","author":"Luchini","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2022.06.009_bib36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib37","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.3390\/cancers13133119","article-title":"Tumor mutational burden as a potential biomarker for immunotherapy in pancreatic cancer: systematic review and still-open questions","volume":"13","author":"Lawlor","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.humpath.2022.06.009_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2022.2021397","article-title":"Refining targeted therapeutic approaches in pancreatic cancer: from histology and molecular pathology to the clinic","volume":"26","author":"Mattiolo","year":"2022","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.humpath.2022.06.009_bib39","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/MPA.0000000000001588","article-title":"Medullary pancreatic carcinoma due to somatic POLE mutation: a distinctive pancreatic carcinoma with marked long-term survival","volume":"49","author":"Kryklyva","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.humpath.2022.06.009_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11864-021-00894-5","article-title":"Treatment approach to adenocarcinoma of the ampulla of vater","volume":"22","author":"Patel","year":"2021","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib41","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4251\/wjgo.v10.i11.370","article-title":"Ampulla of Vater carcinoma: molecular landscape and clinical implications","volume":"10","author":"Pea","year":"2018","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib42","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater","volume":"31","author":"Chang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib43","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000863","article-title":"Immunohistochemical classification of ampullary carcinomas: critical reappraisal fails to confirm prognostic relevance for recently proposed panels, and highlights MUC5AC as a strong prognosticator","volume":"41","author":"Xue","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.path.2020.05.005","article-title":"Approaches to biopsy and resection specimens from the ampulla","volume":"13","author":"Xue","year":"2020","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2022.06.009_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma","volume":"29","author":"Yachida","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2022.06.009_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000001999","article-title":"Ampulla of vater carcinoma: sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations","volume":"267","author":"Mafficini","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.humpath.2022.06.009_bib47","article-title":"Development and validation of a new lymph node ratio-based staging system for ampullary carcinoma after curative pancreaticoduodenectomy","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/jjco\/hyy086","article-title":"Prognostic factors of non-ampullary duodenal adenocarcinoma","volume":"48","author":"Hirashita","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MPA.0000000000001194","article-title":"Perineural invasion is a strong prognostic moderator in ampulla of vater carcinoma: a meta-analysis","volume":"48","author":"Luchini","year":"2019","journal-title":"Pancreas"},{"key":"10.1016\/j.humpath.2022.06.009_bib50","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/PAS.0b013e3181f0b05a","article-title":"Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas","volume":"34","author":"Ohike","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/MEG.0000000000000520","article-title":"Extranodal extension in N1-adenocarcinoma of the pancreas and papilla of Vater: a systematic review and meta-analysis of its prognostic significance","volume":"28","author":"Luchini","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.humpath.2022.06.009_bib52","doi-asserted-by":"crossref","first-page":"58001","DOI":"10.18632\/oncotarget.11156","article-title":"KRAS mutation as a prognostic factor in ampullary adenocarcinoma: a meta-analysis and review","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2022.06.009_bib53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1054\/bjoc.2000.1567","article-title":"Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis","volume":"84","author":"Moore","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib54","first-page":"1841","article-title":"Cancers of the papilla of vater: mutator phenotype is associated with good prognosis","volume":"3","author":"Achille","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2022.06.009_bib55","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.46.6.842","article-title":"Cancer of the ampulla of Vater: chromosome 17p allelic loss is associated with poor prognosis","volume":"46","author":"Scarpa","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.humpath.2022.06.009_bib56","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1002\/cncr.33135","article-title":"Frequency and clinicopathologic associations of DNA mismatch repair protein deficiency in ampullary carcinoma: routine testing is indicated","volume":"126","author":"Xue","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib57","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","article-title":"Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer","volume":"28","author":"Sargent","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib58","series-title":"WHO classification of tumours editorial board. Digestive system tumours","year":"2019"},{"key":"10.1016\/j.humpath.2022.06.009_bib59","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.3748\/wjg.v23.i45.7945","article-title":"Pancreatic acinar cell carcinoma: a review on molecular profiling of patient tumors","volume":"23","author":"Al-Hader","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.009_bib60","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1634\/theoncologist.2011-0231","article-title":"Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy","volume":"16","author":"Lowery","year":"2011","journal-title":"Oncol"},{"key":"10.1016\/j.humpath.2022.06.009_bib61","first-page":"162","article-title":"Pancreatic acinar cell carcinoma: a multi-center series\u00a0on clinical characteristics and treatment outcomes","volume":"S1424\u20133903","author":"Sridharan","year":"2021","journal-title":"Pancreatology"},{"key":"10.1016\/j.humpath.2022.06.009_bib62","article-title":"Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib: a case report","volume":"97","author":"Li","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.humpath.2022.06.009_bib63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41379-019-0373-y","article-title":"RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas","volume":"33","author":"Chou","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/modpathol.2017.106","article-title":"A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms","volume":"31","author":"Wang","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib65","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0002-9440(10)64917-6","article-title":"Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC\/beta-catenin pathway","volume":"160","author":"Abraham","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib66","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/path.4310","article-title":"Whole-exome sequencing of pancreatic neoplasms with acinar differentiation","volume":"232","author":"Jiao","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib67","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MPA.0000000000000190","article-title":"DNA mismatch repair abnormalities in acinar cell carcinoma of\u00a0the\u00a0pancreas: frequency and clinical significance","volume":"43","author":"Liu","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.humpath.2022.06.009_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-21-0152","article-title":"The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms","volume":"29","author":"Venizelos","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2022.06.009_bib69","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s12328-021-01505-4","article-title":"A case of pancreatic neuroendocrine carcinoma with a favorable clinical response to pembrolizumab","volume":"14","author":"Kogami","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.humpath.2022.06.009_bib70","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12022-020-09622-5","article-title":"Long survival and prolonged remission after surgery and chemotherapy in a metastatic mismatch repair deficient pancreatic neuroendocrine carcinoma with MLH1\/PMS2 immunodeficiency and minimal microsatellite shift","volume":"31","author":"Vanoli","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2022.06.009_bib71","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2017.04.002","article-title":"Unraveling molecular pathways of poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: a systematic review","volume":"56","author":"Girardi","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.humpath.2022.06.009_bib72","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s11864-022-00968-y","article-title":"An update on the management of mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN)","volume":"23","author":"Jacob","year":"2022","journal-title":"Curr Treat Options Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772200154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:43:34Z","timestamp":1758645814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772200154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":72,"alternative-id":["S004681772200154X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microsatellite instability in pancreatic and ampullary carcinomas: histology, molecular pathology, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2022.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}